Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
26 participants
INTERVENTIONAL
2010-02-28
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Different Types of Exercise in Type 2 Diabetes
NCT01182948
Resistance Training for the Improvement of Glycemic Control in Prediabetes
NCT06697756
Effects of Progressive Intensity Exercise Training on Glycemic Control in Older Adults
NCT03154073
Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
NCT05203640
Efficacy of Physical Exercise on Glucose Control in People With Prediabetes
NCT05612698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High volume combined aerobic/resistance exercise
High volume combined aerobic/resistance exercise
High volume combined aerobic/resistance exercise
Low volume combined aerobic/resistance exercise
Low volume combined aerobic/resistance exercise
Low volume combined aerobic/resistance exercise
Low volume combined aerobic/resistance exercise
High volume combined A/R exercise, printouts, pedometers
High volume combined aerobic/resistance exercise, printouts, pedometers
High volume combined A/R exercise, printouts, pedometers
High volume combined aerobic/resistance exercise, printouts, pedometers
Low volume combined A/R exercise, printouts, pedometers
Low volume combined aerobic/resistance exercise, printouts, pedometers
Low volume combined A/R exercise, printouts, pedometers
Low volume combined aerobic/resistance exercise, printouts, pedometers
Printed PA information, pedometers and step log group
Printed physical activity information, pedometers and step log group
Printed PA information, pedometers and step log group
Printed PA information, pedometers and step log group
Control
Control
No exercise program provided by the study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High volume combined aerobic/resistance exercise
High volume combined aerobic/resistance exercise
Low volume combined aerobic/resistance exercise
Low volume combined aerobic/resistance exercise
High volume combined A/R exercise, printouts, pedometers
High volume combined aerobic/resistance exercise, printouts, pedometers
Low volume combined A/R exercise, printouts, pedometers
Low volume combined aerobic/resistance exercise, printouts, pedometers
Printed PA information, pedometers and step log group
Printed PA information, pedometers and step log group
Control
No exercise program provided by the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A1c 0.700-0.099
* ability to read and write English
* signed ICF
Exclusion Criteria
* insulin therapy changes in medication for diabetes, BP or Lipids
35 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Calgary
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Sigal, MD
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Calgary
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHREB 22251
Identifier Type: -
Identifier Source: secondary_id
DEAL- 22251
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.